Canaccord Genuity Maintains a 'Buy' on Immunogen (IMGN); Breakthrough P2 Results Support High T-DM1 Potential
Go back to Canaccord Genuity Maintains a 'Buy' on Immunogen (IMGN); Breakthrough P2 Results Support High T-DM1 Potential| Immunogen, Inc. (NASDAQ: IMGN) | Delayed: 31.25 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $31.25 | 52 Week High | $14.22 | |||
| Open | $240.83 | 52 Week Low | $1.51 | |||
| Day High | $31.25 | P/E | N/A | |||
| Day Low | $31.25 | EPS | $-0.36 | |||
| Volume | 670,938 | |||||
| Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) | Delayed: 58.13 -0.07 (0.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $58.20 | 52 Week High | $35.13 | |||
| Open | $57.94 | 52 Week Low | $28.10 | |||
| Day High | $58.28 | P/E | N/A | |||
| Day Low | $57.52 | EPS | $0.00 | |||
| Volume | 258,487 | |||||
